Micralax Citrato/Lauril Sulfoacetato (Sodium Citrate, Sodium Lauryl Sulfoacetate)

Sodium citrate acts as an osmotic agent; when introduced into the colon it draws water from surrounding tissues into the intestinal lumen. This increase in fluid softens the fecal mass and expands the lumen, facilitating easier passage of stool.

The appropriate dose is determined by the prescribing healthcare professional. Typically, a single enema is administered as directed, and the prescriber may repeat the dose if necessary based on the patient’s response and clinical judgement.

Safety data in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician, who will weigh potential benefits against any possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Micralax combines an osmotic agent (sodium citrate) with a surfactant (sodium lauryl sulfoacetate), offering rapid stool softening and reduced surface tension. Compared with stimulant suppositories such as bisacodyl, Micralax generally causes less cramping but may be less effective for severe constipation, making it suitable for mild to moderate cases.

Store the enema at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and extreme temperatures to maintain product integrity.

The patient lies on their left side, bends the knees, and gently inserts the enema tip into the rectum. The prescribed volume is then released, and the patient remains in the same position for a few minutes to allow the solution to act before evacuating.

Serious adverse events, although rare, include severe abdominal pain, rectal bleeding and allergic reactions such as rash, swelling or difficulty breathing. If any of these occur, medical attention should be sought immediately.

Individuals with known hypersensitivity to sodium citrate, sodium lauryl sulfoacetate or any component of the formulation should avoid use. It is also contraindicated in patients with acute intestinal obstruction, severe inflammatory bowel disease, or those who have recently undergone colorectal surgery unless directed by a physician.